Mackall C - Search Results

1

Simplified process for the production of anti-CD19-CAR-engineered T cells.

Tumaini B, Lee DW, Lin T, Castiello L, Stroncek DF, Mackall C, Wayne A, Sabatino M. Tumaini B, et al. Among authors: mackall c. Cytotherapy. 2013 Nov;15(11):1406-15. doi: 10.1016/j.jcyt.2013.06.003. Epub 2013 Aug 28. Cytotherapy. 2013. PMID: 23992830 Free PMC article.

2

Development of a clinical-scale method for generation of dendritic cells from PBMC for use in cancer immunotherapy.

Wong EC, Maher VE, Hines K, Lee J, Carter CS, Goletz T, Kopp W, Mackall CL, Berzofsky J, Read EJ. Wong EC, et al. Among authors: mackall cl. Cytotherapy. 2001;3(1):19-29. doi: 10.1080/146532401753156377. Cytotherapy. 2001. PMID: 12028840

3

Tumor expression of 4-1BB ligand sustains tumor lytic T cells.

Zhang H, Merchant MS, Chua KS, Khanna C, Helman LJ, Telford B, Ward Y, Summers J, Toretsky J, Thomas EK, June CH, Mackall CL. Zhang H, et al. Among authors: mackall cl. Cancer Biol Ther. 2003 Sep-Oct;2(5):579-86. doi: 10.4161/cbt.2.5.545. Cancer Biol Ther. 2003. PMID: 14614331 Free article.

4

Pediatric large-volume leukapheresis: a single institution experience with heparin versus citrate-based anticoagulant regimens.

Bolan CD, Yau YY, Cullis HC, Horwitz ME, Mackall CL, Barrett AJ, Malech HL, Rehak NN, Wayne AS, Leitman SF. Bolan CD, et al. Among authors: mackall cl. Transfusion. 2004 Feb;44(2):229-38. doi: 10.1111/j.1537-2995.2004.00668.x. Transfusion. 2004. PMID: 14962314

5

Thromboembolic events in children and young adults with pediatric sarcoma.

Paz-Priel I, Long L, Helman LJ, Mackall CL, Wayne AS. Paz-Priel I, et al. J Clin Oncol. 2007 Apr 20;25(12):1519-24. doi: 10.1200/JCO.2006.06.9930. J Clin Oncol. 2007. PMID: 17442994

6

Immune-based therapeutics for pediatric cancer.

Capitini CM, Mackall CL, Wayne AS. Capitini CM, et al. Expert Opin Biol Ther. 2010 Feb;10(2):163-78. doi: 10.1517/14712590903431022. Expert Opin Biol Ther. 2010. PMID: 19947897 Free PMC article. Review.

7

Immunotherapy of childhood cancer: from biologic understanding to clinical application.

Wayne AS, Capitini CM, Mackall CL. Wayne AS, et al. Curr Opin Pediatr. 2010 Feb;22(1):2-11. doi: 10.1097/MOP.0b013e3283350d3e. Curr Opin Pediatr. 2010. PMID: 19952749 Free PMC article. Review.

8

Activating signals dominate inhibitory signals in CD137L/IL-15 activated natural killer cells.

Zhang H, Cui Y, Voong N, Sabatino M, Stroncek DF, Morisot S, Civin CI, Wayne AS, Levine BL, Mackall CL. Zhang H, et al. J Immunother. 2011 Mar;34(2):187-95. doi: 10.1097/CJI.0b013e31820d2a21. J Immunother. 2011. PMID: 21304401 Free PMC article.

9

Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomas.

Baird K, Fry TJ, Steinberg SM, Bishop MR, Fowler DH, Delbrook CP, Humphrey JL, Rager A, Richards K, Wayne AS, Mackall CL. Baird K, et al. Biol Blood Marrow Transplant. 2012 May;18(5):698-707. doi: 10.1016/j.bbmt.2011.08.020. Epub 2011 Sep 5. Biol Blood Marrow Transplant. 2012. PMID: 21896345 Free PMC article. Clinical Trial.

10

The future is now: chimeric antigen receptors as new targeted therapies for childhood cancer.

Lee DW, Barrett DM, Mackall C, Orentas R, Grupp SA. Lee DW, et al. Among authors: mackall c. Clin Cancer Res. 2012 May 15;18(10):2780-90. doi: 10.1158/1078-0432.CCR-11-1920. Clin Cancer Res. 2012. PMID: 22589486 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

296 results

Search Page

Filters